MLICM
FBIO icon

Metropolitan Life Insurance Company (MetLife)’s Fortress Biotech FBIO Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-1,399
Closed -$84.8K – 2549
2020
Q3 		$84.8K Buy
+1,399
New +$71.3K ﹤0.01% 2303
2013
Q4 		– Sell
-1,178
Closed -$124K – 2744
2013
Q3 		$124K Hold
1,178
– – ﹤0.01% 2657
2013
Q2 		$152K Buy
+1,178
New +$174K ﹤0.01% 2540

Other funds holding FBIO

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SAM
Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s FBIO Position: Q4 2020 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Fortress Biotech (FBIO) in Q4 2020, closing a stake of 1,399 shares — an estimated $84.8K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in FBIO in Q2 2013 and held it in 3 quarters. The position peaked at $152K in Q2 2013. 87 funds tracked by Wall St. Rank hold FBIO as of Q4 2020.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Fortress Biotech position as of Q4 2020 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 1,399 Fortress Biotech shares in Q4 2020, an estimated $84.8K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Fortress Biotech in Q2 2013 and held it in 3 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Fortress Biotech position peaked at $152K in Q2 2013.
  • 87 funds tracked by Wall St. Rank held Fortress Biotech as of Q4 2020.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q4 2020, filed 16 Feb 2021.